Scarica l'app Stockscreener
30.51
0.69%
0.21
Dopo l'orario di chiusura:
30.51
Precedente Chiudi:
$30.30
Aprire:
$30.35
Volume 24 ore:
314.45K
Relative Volume:
0.89
Capitalizzazione di mercato:
$976.16M
Reddito:
$566.77M
Utile/perdita netta:
$48.16M
Rapporto P/E:
25.64
EPS:
1.19
Flusso di cassa netto:
$274.29M
1 W Prestazione:
+2.42%
1M Prestazione:
+4.09%
6M Prestazione:
+6.57%
1 anno Prestazione:
-4.78%
Intervallo 1D:
$29.99
$30.62
Intervallo di 1 settimana:
$29.27
$30.83
Portata 52W:
$23.23
$42.29
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Nome
Collegium Pharmaceutical Inc
Settore
Telefono
781-713-3699
Indirizzo
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Confronta COLL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
30.51 | 976.16M | 566.77M | 48.16M | 274.29M | 1.19 |
|
RGC
Regencell Bioscience Holdings Ltd
|
10.36 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
159.08 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.26 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.42 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.05 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-05-10 | Downgrade | Needham | Buy → Hold |
| 2024-05-10 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Downgrade | Jefferies | Buy → Hold |
| 2023-08-25 | Reiterato | Needham | Buy |
| 2023-05-02 | Ripresa | Jefferies | Buy |
| 2022-08-08 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-14 | Iniziato | BWS Financial | Sell |
| 2020-05-27 | Iniziato | Guggenheim | Neutral |
| 2020-02-19 | Ripresa | Jefferies | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-05-03 | Ripresa | H.C. Wainwright | Buy |
| 2019-04-12 | Ripresa | Janney | Buy |
| 2019-03-20 | Iniziato | SunTrust | Hold |
| 2019-01-16 | Reiterato | Needham | Buy |
| 2018-03-08 | Reiterato | H.C. Wainwright | Buy |
| 2018-02-07 | Reiterato | Needham | Buy |
| 2017-12-05 | Reiterato | Needham | Buy |
| 2017-09-11 | Iniziato | H.C. Wainwright | Buy |
| 2017-05-11 | Reiterato | Needham | Buy |
| 2016-09-13 | Iniziato | Gabelli & Co | Buy |
| 2015-06-01 | Iniziato | Jefferies | Buy |
| 2015-06-01 | Iniziato | Needham | Buy |
| 2015-06-01 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie
Farther Finance Advisors LLC Boosts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Assenagon Asset Management S.A. Sells 47,897 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Rhumbline Advisers Grows Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
How the (COLL) price action is used to our Advantage - news.stocktradersdaily.com
California State Teachers Retirement System Sells 856 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
COLL Q1 Earnings Call: ADHD Portfolio Drives Growth, Management Details Capital Deployment Priorities - Yahoo Finance
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Position Boosted by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers - Yahoo Finance
Bank of America Corp DE Reduces Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Two Sigma Investments LP Sells 135,582 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
ProShare Advisors LLC Increases Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Millennium Management LLC Raises Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Ameriprise Financial Inc. - Defense World
Deutsche Bank AG Grows Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Jane Street Group LLC Sells 20,543 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) PT at $43.80 - Defense World
Collegium Pharmaceutical's (NASDAQ:COLL) Conservative Accounting Might Explain Soft Earnings - Yahoo Finance
Collegium Pharmaceutical Approves 2025 Equity Incentive Plan - TipRanks
Collegium Pharmaceutical, Inc. to Present at Mizuho Neuro & Ophthalmology Summit and Jefferies Global Healthcare Conference - Nasdaq
Collegium to Participate in Upcoming Investor Conferences - GlobeNewswire
Collegium Pharmaceutical to Present at Mizuho Neuro Summit and Jefferies Healthcare Conference - Stock Titan
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Comerica Bank - Defense World
There May Be Reason For Hope In Collegium Pharmaceutical's (NASDAQ:COLL) Disappointing Earnings - simplywall.st
Voya Investment Management LLC Sells 789 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (COLL) Initiates $25 Million Share Repu - GuruFocus
Collegium Pharmaceutical buys back $25 million in shares By Investing.com - Investing.com Canada
Collegium Pharmaceutical initiates $25M share buyback By Investing.com - Investing.com Canada
Collegium Pharmaceutical Signs $25 Million Accelerated Share Buyback Deal With Jefferies - marketscreener.com
Collegium Announces $25 Million Accelerated Share Repurchase Program - marketscreener.com
Collegium Pharmaceutical initiates $25M share buyback - Investing.com
Collegium Pharmaceutical enters into accelerated share repurchase agreement - MSN
Collegium Pharmaceutical Announces Share Repurchase Agreement - TipRanks
Collegium Pharmaceutical buys back $25 million in shares - Investing.com Australia
Collegium Pharmaceutical Announces $25 Million Accelerated Share Repurchase Agreement with Jefferies LLC - Nasdaq
Collegium pharmaceutical targets $135M in Jornay PM revenue for 2025 amid sales force expansion - MSN
Collegium Pharmaceutical (NASDAQ:COLL) Shares Gap Up – Time to Buy? - Defense World
(COLL) Proactive Strategies - news.stocktradersdaily.com
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2025 Earnings Call Transcript - Insider Monkey
Collegium Pharmaceutical (COLL) Sees Price Target Increase by Pi - GuruFocus
COLL Reaffirms FY25 Adjusted EBITDA Outlook and Highlights Strat - GuruFocus
Collegium Pharmaceutical’s Earnings Call Highlights Growth and Strategic Initiatives - TipRanks
Collegium Pharmaceutical (COLL) Price Target Increased by Piper Sandler | COLL Stock News - GuruFocus
Earnings call transcript: Collegium Pharmaceutical sees strong Q1 2025 growth - Investing.com India
Pacer Advisors, Inc. Reduces Stake in Collegium Pharmaceutical I - GuruFocus
Collegium Pharmaceutical Q1 2025 Earnings Call Transcript - MarketBeat
Collegium Pharmaceutical Inc (COLL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... By GuruFocus - Investing.com Canada
Collegium Pharmaceutical Reports Strong Q1 2025 Growth - TipRanks
Collegium Pharmaceutical: Q1 Earnings Snapshot - New Haven Register
Collegium Pharmaceutical, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:COLL) - Seeking Alpha
Collegium Pharmaceutical Inc Azioni (COLL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Collegium Pharmaceutical Inc Azioni (COLL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Freund John Gordon | Director |
Jun 09 '25 |
Sale |
30.62 |
6,601 |
202,149 |
70,658 |
2.01%
0.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):